Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients

Kidney International

Volumn 82, Issue 1, 2012, Pages 84-89

  Bhan, Ishir ^a   Powe, Camille E ^a   Berg, Anders H ^b   Ankers, Elizabeth ^a   Wenger, Julia B ^a   Karumanchi, S Ananth ^c   Thadhani, Ravi I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

chronic kidney disease; dialysis; free hormone hypothesis; vitamin D; vitamin D deficiency; vitamin D binding protein

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; CALCIUM BLOOD LEVEL; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; NEGRO; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE;

EID: 84862496200     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.19     Document Type: Article

References (34)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
2. Bhan I, Burnett-Bowie S-AM, Ye J et al. Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol 2010; 5: 460-467.
3. Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989; 10: 232-274. (Pubitemid 19223060)
4. Bikle DD, Siiteri PK, Ryzen E et al. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 1985; 61: 969-975. (Pubitemid 16218499)
5. Bikle DD, Gee E, Halloran B et al. Assessment of the free fraction of 25-Hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 1986; 63: 954-959. (Pubitemid 16004301)
6. Powe CE, Ricciardi C, Berg AH et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 2011; 26: 1609-1616.
7. Powe CE, Seely EW, Rana S et al. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension 2010; 56: 758-763.
8. Chun RF, Lauridsen AL, Suon L et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 2010; 95: 3368-3376.
9. Bikle DD, Gee E. Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 1989; 124: 649-654. (Pubitemid 19057050)
10. Safadi FF, Thornton P, Magiera H et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999; 103: 239-251. (Pubitemid 29053142)
11. Hammes A, Andreassen TK, Spoelgen R et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005; 122: 751-762. (Pubitemid 41242639)
12. Lundgren S, Carling T, Hjälm G et al. Tissue distribution of human gp330/megalin, a putative Ca(2+)-sensing protein. J Histochem Cytochem 1997; 45: 383-392. (Pubitemid 27120594)
13. Gutiérrez OM, Farwell WR, Kermah D et al. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporosis Int 2011; 22: 1745-1753.
14. Wolf M, Betancourt J, Chang Y et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 2008; 19: 1379-1388.
15. Zisman AL, Hristova M, Ho LT et al. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 2007; 27: 36-43. (Pubitemid 46364539)
16. Al-Aly Z, Qazi RA, González EA et al. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 2007; 50: 59-68. (Pubitemid 46962851)
17. Jean G, Charra B, Chazot C. Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr 2008; 18: 395-399.
18. Ravani P, Malberti F, Tripepi G et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75: 88-95.
19. Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-1013. (Pubitemid 47530570)
20. González EA, Sachdeva A, Oliver DA et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-510. (Pubitemid 39656665)
21. London GM, Guérin AP, Verbeke FH et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007; 18: 613-620. (Pubitemid 46193327)
22. London GM, Marty C, Marchais SJ et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951. (Pubitemid 38822076)
23. Nigwekar SU, Bhan I, Thadhani R. Nutritional vitamin D in dialysis patients: what to D-iscern? Nephrol Dial Transplant 2011; 26: 764-766.
24. Bhan I, Hewison M, Thadhani R. Dietary vitamin D intake in advanced CKD/ESRD. Semin Dial 2010; 23: 407-410.
25. Drechsler C, Pilz S, Obermayer-Pietsch B et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010; 31: 2253-2261.
26. Drechsler C, Verduijn M, Pilz S et al. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 2011; 26: 1024-1032.
27. Ott SM. Review article: bone density in patients with chronic kidney disease stages 4-5. Nephrology 2009; 14: 395-403.
28. Bhan I, Camargo CA, Wenger J et al. Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J Allergy Clin Immunol 2011; 127: 1302-1304;e1.
29. Forman JP, Giovannucci E, Holmes MD et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063-1069. (Pubitemid 351664326)
30. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007; 71: 134-139. (Pubitemid 46094686)
31. Gombart AF, Bhan I, Borregaard N et al. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis 2009; 48: 418-424.
32. van Hoof HJ, Swinkels LM, Ross HA et al. Determination of non-protein-bound plasma 1,25-dihydroxyvitamin D by symmetric (rate) dialysis. Anal Biochem 1998; 258: 176-183. (Pubitemid 28205042)
33. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672. (Pubitemid 30645223)
34. Correcting the calcium. Br Med J 1977; 1: 598.